United States

Ohio

Name of AuthorInstitutional Affiliation
Appelbaum FRCleveland Clinic Foundation, Myeloma Program, Cleveland, OH, USA.
Byrd JCDivision of Hematology and Oncology, The Ohio State University, Columbus, Ohio 43210, USA.
Byrd, John CDivision of Hematology-Oncology, Department of Medicine, The Ohio State University, Columbus, OH 43210, USA. byrd3@medctr.osu.edu
Christian BADivision of Hematology and Oncology, Ohio State University, Columbus, Ohio 43210, USA.
Gowda ADivision of Hematology and Oncology, The Ohio State University, Columbus, Ohio 43210, USA.
Grever MREastern Cooperative Oncology Group, Division of Hematology-Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA. michael.grever@osumc.edu
Heerema NADivision of Hematology-Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.
Hussein MACleveland Clinic Foundation, Myeloma Program, Cleveland, OH, USA. pubs@swog.org
Larson, Richard ADivision of Hematology-Oncology, Department of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Lin TSDivision of Hematology and Oncology, Ohio State University, Columbus, Ohio 43210, USA.